Research identifies vitamin D receptors (VDR) in breast cancer tumors as a promising prognostic marker, linking VDR presence to tumor characteristics, survival outcomes, and potentially informing treatment strategies.
No Change in Huntington’s Motor Symptoms With Investigational Drug
Investigational laquinimod did not change motor symptoms of Huntington’s disease after 1 year but did significantly reduce caudate volume loss compared with placebo, the phase